293 related articles for article (PubMed ID: 8962216)
1. Limited sampling strategy to estimate exposure to cyclosporine A in renal allograft recipients treated with Sandimmune-Neoral.
Serafinowicz A; Gaciong Z; Baçzkowska T; Rell K; Lao M; Wałaszewski J
Transplant Proc; 1996 Dec; 28(6):3138-9. PubMed ID: 8962216
[No Abstract] [Full Text] [Related]
2. Cyclosporine pharmacokinetics in renal allograft recipients with diabetes mellitus with Sandimmune and Sandimmune Neoral.
Serafinowicz A; Gaciong Z; Baçzkowska T; Durlik M; Lao M
Transplant Proc; 1996 Dec; 28(6):3140-1. PubMed ID: 8962217
[No Abstract] [Full Text] [Related]
3. Pharmacokinetic analysis of Neoral conversion in pediatric and adult renal transplant recipients with poor absorption of Sandimmune.
Pescovitz MD; Henson S; Bodziak K; Book BK; Gonin J; Jindal RM; Leapman SB; Milgrom ML; Filo RS
Transplant Proc; 1996 Aug; 28(4):2165-8. PubMed ID: 8769189
[No Abstract] [Full Text] [Related]
4. Conversion from Sandimmune to Neoral in stable renal and pancreas transplant recipients enhances cyclosporine absorption.
Chapman JR; O'Connell PJ; Bovington KJ; Allen RD
Transplant Proc; 1996 Aug; 28(4):2293-5. PubMed ID: 8769229
[No Abstract] [Full Text] [Related]
5. Conversion from Sandimmune to Neoral and induction therapy with Neoral in pediatric renal transplant recipients.
Hoyer PF; Boekenkamp A; Vester U; Offner G; Brodehl J
Transplant Proc; 1996 Aug; 28(4):2259-61. PubMed ID: 8769218
[No Abstract] [Full Text] [Related]
6. Abbreviated AUC strategy for monitoring cyclosporine microemulsion therapy in the immediate posttransplant period.
Amante AJ; Kahan BD
Transplant Proc; 1996 Aug; 28(4):2162-3. PubMed ID: 8769187
[No Abstract] [Full Text] [Related]
7. Comparison of Neoral and Sandimmune preparations in renal transplant patients--improved pharmacokinetics with neoral.
Warrens AN; Salama A; Waters JB; Lechler RI
Transplant Proc; 1996 Aug; 28(4):2169-70. PubMed ID: 8769190
[No Abstract] [Full Text] [Related]
8. Neoral pharmacokinetics in cynomolgus monkeys: relation to efficacy in renal allografting.
Schuurman HJ; Hengy JC; Ringers J; Vonderscher J; Schuler W; Jonker M
Transplant Proc; 1996 Dec; 28(6):3142-4. PubMed ID: 8962218
[No Abstract] [Full Text] [Related]
9. Conversion from conventional Sandimmun to Neoral therapy in stable renal transplant recipients.
Løkkegaard H; Asmundsson P; Clausen P; Dieperink H; Hansen JM; Heaf J; Jensen SB; Kornerup HJ; Madsen S; Pedersen EB; Poulsen JV; Rasmussen K
Transplant Proc; 1996 Aug; 28(4):2199-201. PubMed ID: 8769199
[No Abstract] [Full Text] [Related]
10. Cyclosporine neoral pharmacokinetics in kidney and heart transplant patients.
Schiavelli R; Sgrosso JL; Sabbatiello R; Castro C; Ahualli L; Pattin M; Vazquez MC
Transplant Proc; 1996 Dec; 28(6):3343-4. PubMed ID: 8962299
[No Abstract] [Full Text] [Related]
11. Changing stable heart transplant recipients from Sandimmune to Neoral.
Dalrymple-Hay M; Meara M; Reynolds L; Backhouse L; Wright D; Holt D; Johnston A; Madden B; Murday A
Transplant Proc; 1996 Aug; 28(4):2285-6. PubMed ID: 8769227
[No Abstract] [Full Text] [Related]
12. Cyclosporine pharmacokinetic profiles in stable renal allograft recipients converting from Sandimmun to Neoral.
Vathsala A; Lee WT; Jacob E; Woo KT
Transplant Proc; 1996 Jun; 28(3):1324-6. PubMed ID: 8658678
[No Abstract] [Full Text] [Related]
13. Pharmacokinetics of oral cyclosporine (Neoral) in heart transplant recipients during the immediate period after surgery.
Banner NR; David OJ; Leaver N; Davis J; Breen J; Johnston A; Yacoub MH
Transpl Int; 2002 Dec; 15(12):649-54. PubMed ID: 12478413
[TBL] [Abstract][Full Text] [Related]
14. Case studies: conversion from Sandimmune to Neoral in stable renal allograft recipients.
Roth D; Miller J
Transplant Proc; 1996 Aug; 28(4):2219-20; discussion 2218. PubMed ID: 8769204
[No Abstract] [Full Text] [Related]
15. Conversion of stable renal transplant recipients from Sandimmune to Sang-35, a Neoral-equivalent cyclosporine formulation, using a dose-adjusted method.
First MR; Weiskittel P; Shah M; Peddi VR; Canafax D; Schroeder TJ
Transplant Proc; 1998 Dec; 30(8):3955-7. PubMed ID: 9865260
[No Abstract] [Full Text] [Related]
16. Oral cyclosporine preparations immediately following renal transplantation.
Katz SM; Amante A; Schoenberg L; Kahan BD
Transplant Proc; 1996 Aug; 28(4):2164. PubMed ID: 8769188
[TBL] [Abstract][Full Text] [Related]
17. Abbreviated kinetic profiles to estimate exposure to CyA in renal allograft recipients treated with Sandimmun-Neoral.
Serafinowicz A; Gaciong Z; Majchrzak J; Baczkowska T; Nowacka E; Gradowska L; Rowiński W; Lao M
Transplant Proc; 1997; 29(1-2):277-9. PubMed ID: 9122994
[No Abstract] [Full Text] [Related]
18. Conversion from cyclosporine to Neoral in pediatric recipients for kidney, liver, and heart transplantation.
Holmberg C; Laine J; Jalanko H; Leijala M; Hoppu K
Transplant Proc; 1996 Aug; 28(4):2262-3. PubMed ID: 8769219
[No Abstract] [Full Text] [Related]
19. Conversion from Sandimmune to Neoral in stable renal transplant recipients. Sandoz Study Group OLN-353.
Pescovitz MD
Transplant Proc; 1996 Aug; 28(4):2196-8. PubMed ID: 8769198
[No Abstract] [Full Text] [Related]
20. Effect of conversion from Sandimmune to Neoral on glomerular filtration rate in stable renal transplant recipients.
Steinmuller D; Dougherty J; Coutee J; Surek D; Swies G; Lewis R
Transplant Proc; 1997; 29(1-2):298-9. PubMed ID: 9123005
[No Abstract] [Full Text] [Related]
[Next] [New Search]
